Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
24.4M
-
Shares change
-
+6.76M
-
Total reported value, excl. options
-
$71.5M
-
Value change
-
+$20.1M
-
Put/Call ratio
-
0.93
-
Number of buys
-
31
-
Number of sells
-
-33
-
Price
-
$2.93
Significant Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q2 2020
82 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share as of Q2 2020.
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.4M shares
of 79.2M outstanding shares and own 30.8% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.75M shares), RA CAPITAL MANAGEMENT, L.P. (4.57M shares), Bain Capital Life Sciences Investors, LLC (3.87M shares), Artal Group S.A. (1.8M shares), BOXER CAPITAL, LLC (1.53M shares), VANGUARD GROUP INC (838K shares), Ikarian Capital, LLC (788K shares), MORGAN STANLEY (535K shares), Eversept Partners, LP (407K shares), and D. E. Shaw & Co., Inc. (358K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.